Haipeng Yu

Tianjin Medical University

SCHOLARLY PAPERS

1

DOWNLOADS

54

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Comparison Outcome of Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Bevacizumab or Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma

Number of pages: 38 Posted: 19 Dec 2024
Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University - Department of Hepatobiliary Cancer, Government of the People's Republic of China - Department of Liver Diseases and Digestive Interventional Radiology, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Government of the People's Republic of China - Department of Liver Diseases and Digestive Interventional Radiology, Tianjin Medical University, Tianjin Medical University - State Key Laboratory of Experimental Hematology and Tianjin Medical University
Downloads 54 (809,100)
Citation 1

Abstract:

Loading...

Hepatocellular carcinoma, Transarterial chemoembolization, Immune checkpoint inhibitors, Atezolizumab plus bevacizumab, Lenvatinib